In between my stint in particle physics and career in AI, I enjoyed 12 years in drug design at CSIRO (Australia's Commonwealth Scientific & Industrial Research Organization) and I remember a fascinating piece of work which came out at that time and got talked around the lab coffee room for a few weeks. It was …
Continue reading Biggest new thing in Biotech? Maybe Fragment-Based Drug Design.